If you were to ask 100 financial experts the best time to claim Social Security, the vast majority would suggest to wait until 70. Ultimately, it's all about life expectancy. According to the Centers for Disease Control and Prevention, if you live to age 65, you probably have more in the tank. At age 65, the life expectancy for women is 85.8 years, and for men it's 83.4. The common school of thoug...
If you were to ask 100 financial experts the best time to claim Social Security, the vast majority would suggest to wait until 70. Ultimately, it's all about life expectancy. According to the Centers for Disease Control and Prevention, if you live to age 65, you probably have more in the tank. At age 65, the life expectancy for women is 85.8 years, and for men it's 83.4. The common school of thought is that the longer you wait to claim Social Security benefits, the larger your benefit will be into your 80s (and beyond). That's because benefits increase by 8% for each year you wait after your full retirement age (FRA), up to age 70. It all depends on you While it's easy to throw out a single age as though everyone should adhere to it, the "perfect" age to retire depends entirely upon your situation. Before determining when you want to claim Social Security benefits, ask yourself the following questions. How much of my pre-retirement income do I expect Social Security to cover? Social Security is designed to replace approximately 40% of your pre-retirement income. For example, if you regularly earn $4,000 per month, Social Security should replace around $1,600 of it. If it doesn't look like you're going to have other sources of income in retirement, working until age 70 may make sense. Consider this: If your Social Security benefits at FRA are scheduled to be $2,000 per month, waiting until age 70 will increase that amount by 24%, to $2,480. Will I be the only person in my household receiving Social Security? Let's say you're the primary breadwinner and your spouse plans to claim Social Security spousal benefits. As your spouse, they're eligible for up to 50% of your benefit at FRA. If you're receiving $2,000, they'll receive $1,000. There's one thing to keep in mind, though. If one of you dies before the other, the lower amount will be eliminated, leaving the surviving spouse with $2,000 a month. How's my health? The best time to claim Social Security may require an ...
Companies to work together at Applied’s EPIC Center in Silicon Valley to accelerate development of advanced DRAM, high-bandwidth memory and NAND storage for future AI applications Joint R&D efforts to leverage engineering teams across California and Idaho to strengthen U.S. leadership in semiconductor innovation SANTA CLARA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today ...
Companies to work together at Applied’s EPIC Center in Silicon Valley to accelerate development of advanced DRAM, high-bandwidth memory and NAND storage for future AI applications Joint R&D efforts to leverage engineering teams across California and Idaho to strengthen U.S. leadership in semiconductor innovation SANTA CLARA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced it is working with Micron Technology to develop next-generation DRAM, high-bandwidth memory (HBM) and NAND solutions that increase the energy-efficient performance of AI systems, bringing together advanced R&D capabilities from Applied’s EPIC Center in Silicon Valley and Micron’s state-of-the-art innovation center in Boise, Idaho to strengthen the semiconductor innovation pipeline in the United States. "Applied Materials and Micron have a long-standing partnership focused on driving higher performance and more energy-efficient advanced memory chips by pushing the boundaries of materials engineering and manufacturing innovation,” said Gary Dickerson, President and CEO of Applied Materials. "We are excited to deepen our collaboration with Micron as a founding partner at the EPIC Center as next-generation memory technologies play an increasingly vital role in the future of AI systems.” "Memory and storage are essential enablers of AI, and sustained innovation in these technologies is critical to unlocking AI’s full potential,” said Sanjay Mehrotra, Chairman, President and CEO of Micron Technology. "Micron has collaborated with Applied Materials for decades to deliver materials engineering innovations for new memory and storage devices, and we are pleased to extend this partnership to Applied’s new EPIC Center in Silicon Valley. Combined with Micron’s U.S.-based R&D and manufacturing hubs, this partnership creates a unique lab-to-fab pipeline to advance American memory innovation.” Teams from Applied Materials and Micron are collaborating on the development of next-ge...
Cassava Sciences ( SAVA ) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The company is working on therapies for conditions such as tuberous sclerosis complex-related epilepsy and other diseases linked to abnormal filamin A activity. The company’s shares will begin trading un...
Cassava Sciences ( SAVA ) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The company is working on therapies for conditions such as tuberous sclerosis complex-related epilepsy and other diseases linked to abnormal filamin A activity. The company’s shares will begin trading under the new ticker FLNA on the Nasdaq Capital Market starting March 11, 2026. “The launch of Filana Therapeutics represents a new beginning for our Company. Growing evidence suggests that filamin A is an important regulator of neuronal development and that modulating filamin A may provide a new approach to treating CNS disorders such as TSC-related epilepsy. Centering our identity on filamin A reflects our dedication to rigorous scientific discovery and to bringing new treatment options to patients and their families,” said Rick Barry , president and chief executive officer of Filana Therapeutics. SAVA shares rose +2.4% premarket at $2.17. More on Cassava Sciences Cassava says DoJ has ended probe into research misconduct Cassava Sciences to pay $31.25M to settle securities class action suit Seeking Alpha’s Quant Rating on Cassava Sciences Historical earnings data for Cassava Sciences Financial information for Cassava Sciences
Agenus ( AGEN ) on Tuesday said it has triggered the first $20M contingent payment under its previously announced strategic collaboration with Zydus Lifesciences. Under the agreement, Agenus may receive up to $50 million in contingent payments tied to botensilimab and balstilimab production orders, with the first $20 million triggered by contracted work orders for CMC and production activities. Th...
Agenus ( AGEN ) on Tuesday said it has triggered the first $20M contingent payment under its previously announced strategic collaboration with Zydus Lifesciences. Under the agreement, Agenus may receive up to $50 million in contingent payments tied to botensilimab and balstilimab production orders, with the first $20 million triggered by contracted work orders for CMC and production activities. The development marks the start of operational activities between Agenus and Zylidac Bio, the U.S.-based biologics manufacturing arm of Zydus Life Sciences. This will help the company carry out key manufacturing activities supporting its development programs without additional capital spending affecting its cash position. Shares +6.42%. More on Agenus Agenus Inc. (AGEN) Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives Transcript Seeking Alpha’s Quant Rating on Agenus Historical earnings data for Agenus Financial information for Agenus
Richard Bernstein Advisors LLC decreased its position in shares of Alphabet Inc. (NASDAQ:GOOG - Free Report) by 51.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,289 shares of the information services provider's stock after selling 42,335 shares during the period. Alphabet comprises ...
Richard Bernstein Advisors LLC decreased its position in shares of Alphabet Inc. (NASDAQ:GOOG - Free Report) by 51.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,289 shares of the information services provider's stock after selling 42,335 shares during the period. Alphabet comprises 0.3% of Richard Bernstein Advisors LLC's investment portfolio, making the stock its 28th biggest position. Richard Bernstein Advisors LLC's holdings in Alphabet were worth $9,812,000 at the end of the most recent quarter. A number of other hedge funds and other institutional investors also recently bought and sold shares of GOOG. Manning & Napier Advisors LLC purchased a new position in shares of Alphabet in the third quarter valued at approximately $32,000. Tripletail Wealth Management LLC purchased a new position in Alphabet in the 3rd quarter valued at approximately $40,000. University of Illinois Foundation acquired a new position in shares of Alphabet in the second quarter worth $31,000. Retirement Wealth Solutions LLC increased its position in shares of Alphabet by 145.0% during the third quarter. Retirement Wealth Solutions LLC now owns 196 shares of the information services provider's stock worth $48,000 after acquiring an additional 116 shares during the period. Finally, Horrell Capital Management Inc. raised its stake in shares of Alphabet by 100.0% in the second quarter. Horrell Capital Management Inc. now owns 200 shares of the information services provider's stock valued at $35,000 after acquiring an additional 100 shares in the last quarter. 27.26% of the stock is currently owned by hedge funds and other institutional investors. Get Alphabet alerts: Sign Up Alphabet Trading Up 2.6% Shares of Alphabet stock opened at $306.01 on Tuesday. The company has a current ratio of 2.01, a quick ratio of 2.01 and a debt-to-equity ratio of 0.11. The company has a fifty day...
Richard Bernstein Advisors LLC cut its holdings in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 54.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,129 shares of the electric vehicle producer's stock after selling 26,064 shares during the quarter. Tesla makes up 0.3% of Richard Bernstein Advisors ...
Richard Bernstein Advisors LLC cut its holdings in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 54.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,129 shares of the electric vehicle producer's stock after selling 26,064 shares during the quarter. Tesla makes up 0.3% of Richard Bernstein Advisors LLC's investment portfolio, making the stock its 27th largest holding. Richard Bernstein Advisors LLC's holdings in Tesla were worth $9,841,000 as of its most recent SEC filing. Other institutional investors and hedge funds also recently made changes to their positions in the company. Chapman Financial Group LLC purchased a new stake in shares of Tesla during the second quarter worth $26,000. Manning & Napier Advisors LLC purchased a new stake in Tesla in the third quarter valued at approximately $29,000. CoreFirst Bank & Trust bought a new stake in shares of Tesla during the 2nd quarter worth $30,000. ESL Trust Services LLC boosted its holdings in shares of Tesla by 1,900.0% in the 2nd quarter. ESL Trust Services LLC now owns 100 shares of the electric vehicle producer's stock worth $32,000 after purchasing an additional 95 shares in the last quarter. Finally, Delos Wealth Advisors LLC bought a new position in Tesla during the second quarter valued at approximately $32,000. Institutional investors own 66.20% of the company's stock. Get Tesla alerts: Sign Up Tesla Trading Up 0.5% TSLA opened at $398.68 on Tuesday. The company has a quick ratio of 1.77, a current ratio of 2.16 and a debt-to-equity ratio of 0.08. Tesla, Inc. has a 52 week low of $214.25 and a 52 week high of $498.83. The stock has a market cap of $1.50 trillion, a PE ratio of 369.15, a PEG ratio of 11.73 and a beta of 1.89. The business has a 50 day moving average of $423.95 and a 200-day moving average of $424.57. Tesla (NASDAQ:TSLA - Get Free Report) last issued its quarterly earnings results on Wednesday, ...
Expense ratios are small numbers that compound into large differences over decades. A fund charging nothing costs exactly that. FZROX, Fidelity’s Zero Total Market Index Fund, has charged investors 0.00% since its August 2018 launch, and after nearly eight years, the performance record is worth examining seriously. What FZROX Is Built to Do FZROX is ... Fidelity’s Zero-Fee ETF Is Quietly Keeping P...
Expense ratios are small numbers that compound into large differences over decades. A fund charging nothing costs exactly that. FZROX, Fidelity’s Zero Total Market Index Fund, has charged investors 0.00% since its August 2018 launch, and after nearly eight years, the performance record is worth examining seriously. What FZROX Is Built to Do FZROX is ... Fidelity’s Zero-Fee ETF Is Quietly Keeping Pace With the S&P 500 And Costs Absolutely Nothing
krblokhin/iStock Editorial via Getty Images Altria ( MO ) has spent decades since the surgeon general's first 1964 warning against smoking and its health impacts . Despite that, since then, the company has generated some of the highest shareholder returns in the market. As we’ll see throughout this article, the company’s continued focus on efficient operations will support continued returns. Altri...
krblokhin/iStock Editorial via Getty Images Altria ( MO ) has spent decades since the surgeon general's first 1964 warning against smoking and its health impacts . Despite that, since then, the company has generated some of the highest shareholder returns in the market. As we’ll see throughout this article, the company’s continued focus on efficient operations will support continued returns. Altria Financials Altria had a strong year, despite a volatile smoking market, as demand for its products remained high. Altria Investor Presentation Altria saw $5.42/share in EPS for the year, with mid-single-digit YoY growth. That enabled the company to continue lofty shareholder returns through both a very reasonable dividend and repurchases. The company’s $8 billion in returns for the year is a number that it can comfortably afford, but still a very strong return level. Altria’s Changing Market At the same time, the smoking market declines that were once so substantial seem like they might not be so substantial anymore. Altria Investor Presentation Altria is expanding its smoke-free portfolio to reduce risk here. That includes new on! PLUS products along with Ploom and Marlboro heated tobacco sticks. Altria, which has substantial experience here with regulatory borders, advocates for a responsible and well-regulated marketplace here. Altria Investor Presentation The U.S. nicotine space has continued to see roughly 2% annual growth in estimated volumes since the start of COVID-19. That’s despite the decline of combustible tobacco as oral tobacco and e-vapor have expanded substantially. These alternative tobacco products now make up ~50% of the market. For e-vapor, the category has seen ~15% YoY growth with 1 billion in fresh volumes. Yet illicit products still represent ~70% of the category. That means a substantial opportunity for Altria as it continues to push less safe illicit products away from the marketplace. This is a strong opportunity for Altria, but it also needs a ...
Amazon.com, Inc. (NASDAQ:AMZN) is one of the top stocks that will make you rich in 10 years. Reuters reported on March 5 that Amazon.com, Inc.’s (NASDAQ:AMZN) cloud unit, AWS, announced the launch of an AI-enabled platform, Amazon Connect Health, aimed at streamlining access to care for patients and reducing administrative work for healthcare providers. The agentic AI-led platform integrates with ...
Amazon.com, Inc. (NASDAQ:AMZN) is one of the top stocks that will make you rich in 10 years. Reuters reported on March 5 that Amazon.com, Inc.’s (NASDAQ:AMZN) cloud unit, AWS, announced the launch of an AI-enabled platform, Amazon Connect Health, aimed at streamlining access to care for patients and reducing administrative work for healthcare providers. The agentic AI-led platform integrates with electronic health records used by clinicians for appointment scheduling, patient verification, clinical documentation, compiling medical histories, and medical coding, according to AWS. In another development, Reuters reported the same day that Amazon.com, Inc. (NASDAQ:AMZN) resolved an issue regarding its software code that had resulted in an hours-long outage on its website for thousands of shoppers. According to outage-tracking website Downdetector.com and reported by Reuters, the disruption had begun around 2:00 p.m. ET, gradually easing to less than 650 incidents of people reporting complications with the website in the United States as of 08:16 p.m. ET from a peak of about 22,000. It also stated that the actual number of affected users may be different from the statistics by Downdetector, as it bases the figures on user-submitted reports. Amazon.com, Inc. (NASDAQ:AMZN) provides its customers with a range of products and services. It offers advanced tools for AR and VR developers through its Amazon Web Services (AWS) platform. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Follow Insider Monkey on Google News.
A pedicab drives past a traffic light that is out due to a power cut in Havana on March 4, 2026. Yamil Lage | Afp | Getty Images U.S. President Donald Trump renewed his threat of a " friendly takeover " of Cuba, saying the communist-run Caribbean island is in "deep trouble." His latest comments come less than a week after he suggested that his administration would turn its sights on Havana after U...
A pedicab drives past a traffic light that is out due to a power cut in Havana on March 4, 2026. Yamil Lage | Afp | Getty Images U.S. President Donald Trump renewed his threat of a " friendly takeover " of Cuba, saying the communist-run Caribbean island is in "deep trouble." His latest comments come less than a week after he suggested that his administration would turn its sights on Havana after U.S. military operations in Iran ended. The Trump administration has sought to ratchet up the pressure on Cuba since the Jan. 3 military operation to depose Venezuelan President Nicolás Maduro, a long-time ally of Cuba's government. The U.S. has effectively cut Havana off from Venezuelan oil, called its government "an unusual and extraordinary threat," and pledged to impose tariffs on any country that supplies it with oil. Speaking at a news conference in Doral, Florida, Trump said on Monday that Secretary of State Marco Rubio was dealing with Cuba's leadership as the country grapples with a worsening economic crisis . "It may be a friendly takeover. It may not be a friendly takeover. It wouldn't matter because they are down to, as they say, fumes," Trump said. "They have no energy. They have no money. They are in deep trouble on a humanitarian basis and we don't want to see that," he added. Cuba's government has denied being in talks with the U.S. government, although it has previously confirmed " communications " between the two administrations. A spokesperson for Cuba's embassy in London did not immediately respond to a CNBC request for comment. The U.S. president and his allies have since spoken publicly about the prospect of Cuba becoming the subject of another major foreign policy move. Read more Trump hints U.S. will turn to Cuba after Iran: 'Just a question of time' Is Cuba next? What the fallout from the Iran war means for Havana What now for Cuba? Trump turns the screws as the island runs out of jet fuel "Cuba's next," Sen. Lindsey Graham, R-S.C., said on Fox News ...
BING-JHEN HONG/iStock Editorial via Getty Images Qualcomm ( QCOM ) was in the spotlight on Tuesday as Bank of America reinstated coverage on the stock with an Underperform rating, stating it only sees “lukewarm” growth ahead for the semiconductor company. “QCOM is a leader in smartphone processors but it’s a mature industry with downside risks from rising memory prices and QCOM’s well-known immine...
BING-JHEN HONG/iStock Editorial via Getty Images Qualcomm ( QCOM ) was in the spotlight on Tuesday as Bank of America reinstated coverage on the stock with an Underperform rating, stating it only sees “lukewarm” growth ahead for the semiconductor company. “QCOM is a leader in smartphone processors but it’s a mature industry with downside risks from rising memory prices and QCOM’s well-known imminent ~$7-8bn loss of Apple business,” analyst Vivek Arya wrote in a note to clients. “QCOM has diversified into auto/IoT and plans to enter AI data center, but benefits could be insufficient to offset mobile headwinds.” Arya has a $145 price target on Qualcomm. Aside from the concerns about the Apple ( AAPL ) business, Samsung ( SSNLF ) is also moving away from Qualcomm, reducing Galaxy share to 75% from 100%. Separately, Chinese handset maker Xiaomi has also upped its semiconductor R&D spending to $7B, which may be a negative for Qualcomm. The company is also likely to be hurt by rising dynamic random access memory costs for some time, as AI server builds have pressured the smartphone market, particularly in China. “Longer-term, QCOM faces intensifying competition across every end-market: MediaTek moving upmarket in handsets, NVDA/Mobileye in auto, and a crowded data center CPU market where we see QCOM’s opportunity at just 10-20% of ARM CPU share (~20% of $60bn TAM), i.e., just $1-2B sales or $0.20-$0.40 EPS,” Arya added. More on Qualcomm Qualcomm: 9% FCF Yield Underscores The Value Case Qualcomm's Weak Guidance Sparks A Mispricing, Not A Structural Shift Qualcomm Earnings: Why The Stock Is Dropping And Where It's Going Next China's Android shipments plunge as inventory builds in contrast to iPhones: Jefferies Qualcomm enters coalition to ensure 6G commercial systems are up and running by 2029
BING-JHEN HONG/iStock Editorial via Getty Images Qualcomm ( QCOM ) was in the spotlight on Tuesday as Bank of America reinstated coverage on the stock with an Underperform rating, stating it only sees “lukewarm” growth ahead for the semiconductor company. “QCOM is a leader in smartphone processors but it’s a mature industry with downside risks from rising memory prices and QCOM’s well-known immine...
BING-JHEN HONG/iStock Editorial via Getty Images Qualcomm ( QCOM ) was in the spotlight on Tuesday as Bank of America reinstated coverage on the stock with an Underperform rating, stating it only sees “lukewarm” growth ahead for the semiconductor company. “QCOM is a leader in smartphone processors but it’s a mature industry with downside risks from rising memory prices and QCOM’s well-known imminent ~$7-8bn loss of Apple business,” analyst Vivek Arya wrote in a note to clients. “QCOM has diversified into auto/IoT and plans to enter AI data center, but benefits could be insufficient to offset mobile headwinds.” Arya has a $145 price target on Qualcomm. Aside from the concerns about the Apple ( AAPL ) business, Samsung ( SSNLF ) is also moving away from Qualcomm, reducing Galaxy share to 75% from 100%. Separately, Chinese handset maker Xiaomi has also upped its semiconductor R&D spending to $7B, which may be a negative for Qualcomm. The company is also likely to be hurt by rising dynamic random access memory costs for some time, as AI server builds have pressured the smartphone market, particularly in China. “Longer-term, QCOM faces intensifying competition across every end-market: MediaTek moving upmarket in handsets, NVDA/Mobileye in auto, and a crowded data center CPU market where we see QCOM’s opportunity at just 10-20% of ARM CPU share (~20% of $60bn TAM), i.e., just $1-2B sales or $0.20-$0.40 EPS,” Arya added. More on Qualcomm Qualcomm: 9% FCF Yield Underscores The Value Case Qualcomm's Weak Guidance Sparks A Mispricing, Not A Structural Shift Qualcomm Earnings: Why The Stock Is Dropping And Where It's Going Next China's Android shipments plunge as inventory builds in contrast to iPhones: Jefferies Qualcomm enters coalition to ensure 6G commercial systems are up and running by 2029